Pregnancy in women with Type 2 diabetes: Who takes metformin and what is the outcome?

Diabetic Medicine

Volumn 23, Issue 3, 2006, Pages 318-322

  Hughes, R C E ^a   Rowan, J A ^b  

^a Department of Medicine ^*  (New Zealand)

^b NATIONAL WOMEN S HOSPITAL   (New Zealand)

Author keywords

Metformin; Neonatal morbidity; Preeclampsia; Pregnancy; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; METFORMIN;

ADULT; BODY MASS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DELIVERY; DRUG FATALITY; FALLOT TETRALOGY; FEMALE; FIRST TRIMESTER PREGNANCY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURITY; RESPIRATORY DISTRESS; REVIEW; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; CHRONIC DISEASE; DELIVERY, OBSTETRIC; DIABETES MELLITUS, TYPE 2; FEMALE; FETAL MORTALITY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MEDICAL AUDIT; METFORMIN; NEW ZEALAND; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME;

EID: 33645049852     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01750.x     Document Type: Review

References (40)

1. Feig DS Palda VA Type 2 diabetes in pregnancy: a growing concern Lancet 2002 359 1690 1692
2. Caballero AE Delgado A Aguilar-Salinas CA Herrera AN Castillo JL Cabrera T et al. The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial J Clin Endocrinol Metab 2004 89 3943 3948
3. Hundal RS Inzucchi SE Metformin: new understandings, new uses Drugs 2003 63 1879 1894
4. Kirpichnikov D McFarlane SI Sowers JR Metformin: an update Ann Intern Med 2002 137 25 33
5. Yamashita H Shao J Friedman JE Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus Clin Obstet Gynecol 2000 43 87 98
6. Elliott BD Schenker S Langer O Johnson R Prihoda T Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer Am J Obstet Gynecol 1994 171 653 660
7. Elliott BD Langer O Schuessling BA Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin Am J Obstet Gynecol 1997 176 527 530
8. Hague W Davoren P McIntyre H Metformin crosses the placenta AbstMedicine and Pregnancy Fremantle 2003 Australia Novo Nordisk
9. Piacquadio K Hollingsworth DR Murphy H Effects of in-utero exposure to oral hypoglycaemic drugs Lancet 1991 338 866 869
10. Gutzin SJ Kozer E Magee LA Feig DS Koren G The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis Can J Clin Pharmacol 2003 10 179 183
11. Coetzee EJ Jackson WP Oral hypoglycaemics in the first trimester and fetal outcome S Afr Med J 1984 65 635 637
12. Harborne L Fleming R Lyall H Sattar N Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome Lancet 2003 361 1894 1901
13. Glueck CJ Goldenberg N Pranikoff J Loftspring M Sieve L Wang P Height, weight, and motor-social developments during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy Hum Reprod 2004 19 1323 1330
14. Glueck CJ Wang P Goldenberg N Sieve-Smith L Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin Hum Reprod 2002 17 2858 2864
15. Glueck CJ Bornovali S Pranikoff J Goldenberg N Dharashivkar S Wang P Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome Diabet Med 2004 21 829 836
16. Hellmuth E Damm P Molsted-Pederson L Congenital malformations in offspring of diabetic women treated with oral hypoglycaemic agents during embryogenesis Diabet Med 1994 11 471 474
17. Glueck CJ Phillips H Cameron D Sieve-Smith L Wang P Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study Fertil Steril 2001 75 46 52
18. Jakubowicz DJ Iuorno MJ Jacubowicz S Roberts KA Nestler JE Effects of metformin on early pregnancy loss in the polycystic ovary syndrome J Clin Endocrinol Metab 2002 87 524 529
19. Heard MJ Pierce A Carson SA Buster JE Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome Fertil Steril 2002 77 669 673
20. Glueck CJ Goldenberg N Wang P Loftspring M Sherman A Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy Hum Reprod 2004 19 510 524
21. Glueck CJ Wang P Kobayashi S Phillips H Sieve-Smith L Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome Fertil Steril 2002 77 520 525
22. Coetzee EJ Jackson WP Pregnancy in established non-insulin-dependent diabetics S Afr Med J 1980 58 795 802
23. Coetzee EJ Jackson WP Metformin in management of pregnant insulin-independent diabetics Diabetologia 1979 16 241 245
24. Coetzee EJ Jackson WP The management of non-insulin-dependent diabetes during pregnancy Diabetes Res 1986 1 281 287
25. Vanky E Salvesen KA Heimstad R Fougner KJ Romunstad P Carlsen SM Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomised study Hum Reprod 2004 19 1734 1740
26. Hellmuth E Damm P Molsted-Pederson L Oral hypoglycaemic agents in 118 diabetic pregnancies Diabet Med 2000 17 507 511
27. Thadhani R Stampfer MJ Hunter DJ Manson JE Solomon CG Curhan GC High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy Obstet Gynecol 1999 94 543 550
28. Weiss JL Malone FD Emig D Ball RH Nyberg DA Comstock CH et al. Obesity, obstetric complications and cesarean delivery rate - a population-based screening study Am J Obstet Gynecol 2004 190 1091 1097
29. O'Brien TE Ray JG Chan WS Maternal body mass index and the risk of preeclampsia: a systematic overview [see comment] Epidemiology 2003 14 368 374
30. Brown MA Hague WM Higgins J McCowan L Oats J Peek MJ Rowan JA Walters BN The detection, investigation and management of hypertension in pregnancy: full consensus statement Aust N Z J Obstet Gynaecol 2000 40 139 155
31. Beeby PJ Bhutap T Taylor LK New South Wales population-based birthweight percentile charts J Paediatr Child Health 1996 32 512 518
32. Cundy T Slee F Gamble G Neale L Hypertensive disorders of pregnancy in type 1 and type 2 diabetes Diabet Med 2002 19 482 489
33. Dunne F Brydon P Smith K Gee H Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002 Diabet Med 2003 20 734 738
34. Caballero AE Endothelial dysfunction in obesity and insulin resistance: a link to diabetes and heart disease Obes Res 2003 11 1278 1289
35. de Vries MJ Dekker GA Schoemaker J Higher risk of preeclampsia in the polycystic ovary syndrome: a case control study Eur J Obstet Gynecol Reprod Biol 1998 76 91 95
36. Wolf M Sandler L Munoz K Hsu K Ecker JL Thadhani R First trimester insulin resistance and subsequent preeclampsia: a prospective study J Clin Endocrinol Metab 2002 87 1563 1568
37. Redman CW Sacks GP Sargent IL Preeclampsia: an excessive maternal inflammatory response to pregnancy Am J Obstet Gynecol 1999 180 499 506
38. Dabelea D Hanson RL Lindsay RS Pettitt DJ Imperatore G Gabir MM et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity Diabetes 2000 49 2208 2211
39. Silverman BL Metzger BE Cho NH Loeb CA Impaired glucose tolerance in adolescent offspring of diabetic mothers Diabetes Care 1995 18 611 617
40. Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC Amniotic fluid insulin concentration as a predictor of obesity Arch Dis Child 1990 65 1050 1052